Alabama Cannabis Director Confirms Retirement Plan but Will Stay Through Licensing
Alabama's medical cannabis commission director has confirmed he will announce plans to retire at an October 29 meeting, after conflicting reports earlier in the week. He intends to remain in the role until the agency finishes its integrated licensing process, which he expects may conclude around the start of next year. The article describes the timeline and the director's preference not to set a specific departure date before that work is complete.
John McMillan, executive director of the Alabama Medical Cannabis Commission, first denied retirement reports on Monday before confirming Tuesday that he would announce plans to retire at the commission’s October 29 meeting. He said commissioners could then decide how to search for a successor.
McMillan intends to remain until the integrated licensing round ends, possibly near January. The commission has rescinded three earlier license award attempts and moved to contested-case hearings; a three-week hearing has finished, with an administrative law judge’s recommendation expected soon. The program reports nearly 2,500 patients, 58 physicians, and three more dispensaries expected by late October.
The leadership timeline may matter most to patients, physicians, dispensary operators, and license applicants who depend on a stable regulatory process. A delayed departure could preserve continuity while the final licensing decision is pending, potentially reducing uncertainty for businesses preparing to launch. At the same time, any perceived instability could complicate planning for applicants and delay patient access if decisions slip. The effect may depend on whether the commission completes its licensing work on the expected timeline and how clearly it communicates succession plans.